Navigating Economic Resilience Through Life Sci...

By João L. Carapinha

January 20, 2026

Navigating a Leaderless Global Economy Through Life Sciences Investment In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Aligning Medical Schemes with National Health Insurance South Africa